ChemicalBook > Product Catalog >API >Inhibitors >CYCLO (ARG-GLY-ASP-D-PHE-LYS)

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Structure
CAS No.
161552-03-0
Chemical Name:
CYCLO (ARG-GLY-ASP-D-PHE-LYS)
Synonyms
CYCLO;c(RGDfK);CYCLO(-RGDFK);Cyclo(RGDfK) peptide;RGDFK;cyclo(RGD-DPhe-K);Cyclo (-RGDfK) TFA;Cyclo(-RGDfK), >98%;Cyclic RGDFK peptide;ARG-GLY-ASP-D-PHE-LYS
CBNumber:
CB1186608
Molecular Formula:
C27H41N9O7
Molecular Weight:
603.67
MOL File:
Mol file
Modify Date:
2024/7/2 8:55:00

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Properties

Melting point 191℃ (decomposition)
Density 1.47±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility ≥30.19 mg/mL in DMSO; insoluble in EtOH; ≥59.2 mg/mL in H2O
form Powder
pka 4.01±0.10(Predicted)
color White to off-white

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Chemical Properties,Uses,Production

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 139)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Alpha Biopharmaceuticals Co., Ltd +86-15542445688 China 888 58 Inquiry
Hangzhou FandaChem Co.,Ltd. 008657128800458; +8615858145714 China 9343 55 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32836 60 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10311 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Shanghai Longyu Biotechnology Co., Ltd. +8619521488211 China 2534 58 Inquiry
Fuxin Pharmaceutical +86-021-021-50872116 +8613122107989 China 10297 58 Inquiry
Hebei Yanxi Chemical Co., Ltd. +8617531190177 China 5873 58 Inquiry
Hubei Ipure Biology Co., Ltd +8613367258412 China 10326 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 24099 58 Inquiry

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Spectrum

CYCLO (ARG-GLY-ASP-D-PHE-LYS) cyclo (Arg-Gly-Asp-Phe-Lys) Cyclic RGDFK peptide Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-L-lysyl) Cyclo(-Arg-Gly-Asp-D-Phe-Lys) Trifluoroacetate salt Cyclo (-RGDfK) TFA CYCLO(RGDFK) PEPTIDE;CYCLIC RGDFK PEPTIDE Cyclo(-RGDfK)(free base) C(RGDFK);CYCLO (RGDFK) Cyclo(-RGDfK), >98% Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-lysyl) CYCLO (ARG-GLY-ASP-D-PHE-LYS) USP/EP/BP CYCLO(-RGDFK) c(RGDfK) Cyclo(RGDfK) peptide CYCLO cyclo(RGD-DPhe-K) Cyclo(-RGDfK),inhibit,Microvasculature,cancer,Integrin,tumoral cell,αvβ3 integrin,Cyclo(RGDfK),ligand,Inhibitor,Cyclo( RGDfK) ARG-GLY-ASP-D-PHE-LYS RGDFK 2-((2S,5R,8S,11S)-8-(4-Aminobutyl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid 161552-03-0 C27H41N9O7 peptide RGD